Klacid I.V.

Clarithromycin, the active ingredient in Klacid I.V., is a macrolide antibiotic presented as an intravenous solution for intravenous use. It is employed to treat a variety of bacterial infections, including community‑acquired pneumonia, acute bacterial sinusitis, skin and soft‑tissue infections, and other severe bacterial infections in adult patients.

GNH USA supplies Klacid I.V. as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals worldwide. The company adheres to stringent quality standards and provides reliable global distribution for healthcare institutions.

Clarithromycin is a macrolide antibiotic used to treat bacterial infections affecting the respiratory, sinus, skin, and systemic compartments.

- Community‑acquired pneumonia: achieves bacterial eradication and clinical improvement in adult patients. - Acute bacterial sinusitis: reduces sinus inflammation and resolves infection symptoms. - Skin and soft‑tissue infections: clears pathogenic bacteria and promotes wound healing. - Severe bacterial infections: provides broad‑spectrum coverage for serious systemic infections.

Clarithromycin may cause a range of adverse reactions, varying from mild to serious.

Common Side Effects: - Nausea: mild to moderate stomach upset. - Diarrhea: frequent loose stools. - Taste alteration: metallic or bitter taste. - Headache: mild headache.

Serious or Rare Side Effects: - Anaphylaxis: severe allergic reaction with rash, swelling, and breathing difficulty. - QT interval prolongation: may lead to cardiac arrhythmias. - Clostridioides difficile‑associated diarrhea: severe colitis requiring medical attention.

When using Klacid I.V., consider the following precautions.

- Renal impairment: monitor renal function and adjust therapy as needed. - Hepatic impairment: use with caution; observe liver function tests. - Pregnancy Category B: weigh maternal benefits against potential fetal risks. - Concomitant QT‑prolonging agents: assess cardiac risk and consider ECG monitoring. - Known macrolide allergy: avoid use to prevent hypersensitivity reactions. - Store at 2-8°C: keep refrigerated, protect from light, do not freeze.

Clarithromycin can interact with several medicines; some require avoidance while others need monitoring.

Major Interactions (Avoid): - Co‑administration with other macrolides (e.g., erythromycin): additive QT prolongation risk. - Cisapride: may cause serious cardiac arrhythmias. - Pimozide: increased plasma levels leading to neurotoxicity.

Moderate Interactions (Monitor Closely): - Warfarin: clarithromycin can raise INR; monitor coagulation parameters. - Theophylline: plasma concentrations may increase; observe for toxicity signs. - Carbamazepine: may reduce clarithromycin levels, decreasing efficacy.